Vimarsana
Biggest News Aggregation in the World

Dan Lahav News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dan Lahav. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dan Lahav Today - Breaking & Trending Today

The widening web of effective altruism in AI security | The AI Beat - Vimarsana News

The widening web of effective altruism in AI security | The AI Beat

A follow up on a VentureBeat story last week adds context about the web of effective altruism connections in AI security circles.

Why Anthropic and OpenAI are obsessed with securing LLM model weights - Vimarsana News

Why Anthropic and OpenAI are obsessed with securing LLM model weights

Why AI model companies are concerned about malicious actors accessing the weights of the most sophisticated and powerful LLMs.

From TPG Capital to EQT Partners, here are five upcomers in Australian private equity - Vimarsana News

From TPG Capital to EQT Partners, here are five upcomers in Australian private equity

Private equity is empowering its younger dealmakers to lead deals like Nitro Software and Greencross, but more can be done to improve gender diversity.

Source: afr.com
Meet the world champions of debating - Vimarsana News

Meet the world champions of debating

As we sat down with Sourodip Paul and Sajid Asbat Khandaker – team BRAC A, winners of this year’s World Universities Debating Championship (WUDC 2022) – at The Daily Star, we realised the gravity of the task set ahead of us: we were about to interview the world champions of debating. As aspiring debaters, this opportunity to meet our idols felt almost unreal.

Israeli tech can identify genetic disorders in embryo with simple blood test - Vimarsana News

Israeli tech can identify genetic disorders in embryo with simple blood test

IdentifAI Genetics, firm which specializes in artificial intelligence, aims to get the product that can read embryo’s entire DNA and provide in-depth analysis, to market within 2 years; technology could also be used to identify early markers of cancer